ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway
Abstract Background: Despite advancements in thyroid cancer (THCA) treatment, the prognosis for advanced cases remains poor. Cellular senescence is crucial…
Abstract Background: Despite advancements in thyroid cancer (THCA) treatment, the prognosis for advanced cases remains poor. Cellular senescence is crucial…